No Role for Reintroducing OPV into the United States with Respect to Controlling COVID‐19 [Response to the letter to the Editor by Chumakov et al.]-Reference-Cited by-同舟云学术

No Role for Reintroducing OPV into the United States with Respect to Controlling COVID‐19 [Response to the letter to the Editor by Chumakov et al.]

Published:2021-02 Issue:2 Volume:41 Page:389-392
ISSN:0272-4332
Container-title:Risk Analysis
language:en
Short-container-title:Risk Analysis

Author:

Thompson Kimberly M.¹,Kalkowska Dominika A.¹,Badizadegan Kamran¹

Affiliation:

1. Kid Risk, Inc. 7512 Dr. Phillips Blvd. #50‐523 Orlando FL 32819 USA

Publisher

Wiley

Subject

Physiology (medical),Safety, Risk, Reliability and Quality

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/risa.13671

Reference22 articles.

1. Can existing live vaccines prevent COVID-19?

2. Letter to the Editor;Chumakov K.;Risk Anal,2021

3. Cohn M.(2020).Old polio vaccine could offer some protection from coronavirus University of Maryland experts expect. Retrieved fromhttps://www.baltimoresun.com/coronavirus/bs-hs-polio-vaccine-for-coronavirus-20200612-xjszq7fqjnejpb6vfhfavxnneq-story.html

4. Global Surveillance and the Value of Information: The Case of the Global Polio Laboratory Network

5. Economic analysis of the global polio eradication initiative

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame;Medical Decision Making;2023-08-14

2. Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences;Risk Analysis;2023-06-21

3. Outbreak management strategies for cocirculation of multiple poliovirus types;Vaccine;2023-06

4. Health economic analyses of secondary vaccine effects: a systematic review and policy insights;Expert Review of Vaccines;2022-01-12

5. Modeling and Managing Poliovirus Risks: We are Where we are…;Risk Analysis;2021-02